No. 18-1502

Brian Mark Burmaster v. Eli Lilly and Company

Lower Court: Sixth Circuit
Docketed: 2019-06-03
Status: Denied
Type: Paid
Tags: 6th-amendment civil-rights constitutional-rights drug-marketing due-process free-speech government-action government-intervention government-overreach government-regulation medical-ethics pharmaceutical pharmaceutical-liability pharmaceutical-litigation sixth-amendment
Key Terms:
Securities Immigration
Latest Conference: 2019-10-01
Question Presented (AI Summary)

If a company's manufactured and marketed product is cited by the US Government as a 'miracle drug' to restore a criminal defendant's Sixth Amendment right to a speedy and public trial, should the pharmaceutical company issue a cease and desist order to the US Government?

Question Presented (OCR Extract)

QUESTION PRESENTED The primary federal question that I ask is: : If a company’s manufactured and marketed product, such as Eli Lilly’s Zyprexa is cited by the US Government Quack (called a medical doctor?) as the miracle yO. . drug to restore an extradited criminal defendant’s Sixth Amendment of our sacred US Constitution right to a speedy and public trial by an impartial jury, shouldn’t that American pharmaceutical company issue a cease and desist order immediately to that US Government Quack?

Docket Entries

2019-10-07
Petition DENIED.
2019-07-17
DISTRIBUTED for Conference of 10/1/2019.
2019-05-30
Petition for a writ of certiorari filed. (Response due July 3, 2019)

Attorneys

Brian M. Burmaster
Brian Mark Burmaster — Petitioner